| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |